Background: During the 2014-2015 influenza season in the United States, 256 cases of influenza-associated parotitis were reported from 27 states. We conducted a case-control study and laboratory investigation to further describe this rare clinical manifestation of influenza. Methods: During February 2015-April 2015, we interviewed 50 cases (with parotitis) and 124 ill controls (without parotitis) with laboratory-confirmed influenza; participants resided in 11 states and were matched by age, state, hospital admission status, and specimen collection date. Influenza viruses were characterized using real-time polymerase chain reaction and next-generation sequencing. We compared cases and controls using conditional logistic regression. Specimens from additional reported cases were also analyzed. Results: Cases, 73% of whom were aged <20 years, experienced painful (86%), unilateral (68%) parotitis a median of 4 (range, 0-16) days after onset of systemic or respiratory symptoms. Cases were more likely than controls to be male (76% vs 51%; P = .005). We detected influenza A(H3N2) viruses, genetic group 3C.2a, in 100% (32/32) of case and 92% (105/108) of control specimens sequenced (P = .22). Influenza B and A(H3N2) 3C.3 and 3C.3b genetic group virus infections were detected in specimens from additional cases. Conclusions: Influenza-associated parotitis, as reported here and in prior sporadic case reports, seems to occur primarily with influenza A(H3N2) virus infection. Because of the different clinical and infection control considerations for mumps and influenza virus infections, we recommend clinicians consider influenza in the differential diagnoses among patients with acute parotitis during the influenza season.
Background: During the 2014-2015 influenza season in the United States, 256 cases of influenza-associated parotitis were reported from 27 states. We conducted a case-control study and laboratory investigation to further describe this rare clinical manifestation of influenza. Methods: During February 2015-April 2015, we interviewed 50 cases (with parotitis) and 124 ill controls (without parotitis) with laboratory-confirmed influenza; participants resided in 11 states and were matched by age, state, hospital admission status, and specimen collection date. Influenza viruses were characterized using real-time polymerase chain reaction and next-generation sequencing. We compared cases and controls using conditional logistic regression. Specimens from additional reported cases were also analyzed. Results: Cases, 73% of whom were aged <20 years, experienced painful (86%), unilateral (68%) parotitis a median of 4 (range, 0-16) days after onset of systemic or respiratory symptoms. Cases were more likely than controls to be male (76% vs 51%; P = .005). We detected influenza A(H3N2) viruses, genetic group 3C.2a, in 100% (32/32) of case and 92% (105/108) of control specimens sequenced (P = .22). Influenza B and A(H3N2) 3C.3 and 3C.3b genetic group virus infections were detected in specimens from additional cases. Conclusions: Influenza-associated parotitis, as reported here and in prior sporadic case reports, seems to occur primarily with influenza A(H3N2) virus infection. Because of the different clinical and infection control considerations for mumps and influenza virus infections, we recommend clinicians consider influenza in the differential diagnoses among patients with acute parotitis during the influenza season.
Authors: Claudia H Krause; Pamela J Molyneaux; Darrel O Ho-Yen; Paul McIntyre; William F Carman; Kate E Templeton Journal: J Clin Virol Date: 2006-12-04 Impact factor: 3.168
Authors: J S Rota; J C Turner; M K Yost-Daljev; M Freeman; D M Toney; E Meisel; N Williams; S B Sowers; L Lowe; P A Rota; L A Nicolai; L Peake; W J Bellini Journal: J Med Virol Date: 2009-10 Impact factor: 2.327
Authors: Danuta M Skowronski; Catharine Chambers; Suzana Sabaiduc; Gaston De Serres; Anne-Luise Winter; James A Dickinson; Mel Krajden; Jonathan B Gubbay; Steven J Drews; Christine Martineau; Alireza Eshaghi; Trijntje L Kwindt; Nathalie Bastien; Yan Li Journal: Clin Infect Dis Date: 2016-03-29 Impact factor: 9.079
Authors: Lina I Elbadawi; Pamela Talley; Melissa A Rolfes; Alexander J Millman; Erik Reisdorf; Natalie A Kramer; John R Barnes; Lenee Blanton; Jaime Christensen; Stefanie Cole; Tonya Danz; John J Dreisig; Rebecca Garten; Thomas Haupt; Beth M Isaac; Mary Anne Jackson; Anna Kocharian; Daniel Leifer; Karen Martin; Lisa McHugh; Rebecca J McNall; Jennifer Palm; Kay W Radford; Sara Robinson; Jennifer B Rosen; Senthilkumar K Sakthivel; Peter Shult; Anna K Strain; George Turabelidze; Lori A Webber; Meghan Pearce Weinberg; David E Wentworth; Brett L Whitaker; Lyn Finelli; Michael A Jhung; Ruth Lynfield; Jeffrey P Davis Journal: Clin Infect Dis Date: 2018-08-01 Impact factor: 9.079
Authors: Rosy Priya L Kodiyanplakkal; Jennifer M Laplante; Lars F Westblade; Koen van Besien; Mirella Salvatore; Kirsten St George Journal: Open Forum Infect Dis Date: 2019-11-18 Impact factor: 3.835